Intranasal Administration of Interleukin-1 Receptor Antagonist in a Transient Focal Cerebral Ischemia Rat Model.

Biomol Ther (Seoul) · 2017 · PMC5340539 · PMID 27530114

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

did not reach statistical significancep =0.087so close (0.05 < p ≤ 0.1)

However, the difference in infarct volume between the IN and IP groups did not reach statistical significance ( p =0.087), and neither did the difference between the EC and IP groups ( p =0.099; Fig. 1B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.